Figure 2.
Association between combined analyses of GSTP1-105 and TS-5′ UTR polymorphisms including the TS-5′ G-C SNP and overall survival among patients with advanced gastric cancer. Group A includes patients with only unfavourable genotypes in both genes (n=15). Group B includes either patients homozygous for the GSTP1-105 Val variant or patient with a favourable TS-5′ UTR genotype (n=23) and group C patients are homozygous for GSTP1-105 Val and possess a favourable TS-5′ UTR polymorphism (n=3).